Expression of human ornithine aminotransferase (OAT) in OAT-deficient Chinese hamster ovary celis and fibroblasts of gyrate atrophy patient

Y. Hotta, George Inana

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gyrate atrophy is a hereditary chorioretinal degenerative disease caused by a deficiency of the mitochondrial enzyme, ornithine aminotransferase (OAT). Recent investigations have demonstrated the molecular genetic defects of OAT in gyrate atrophy patients. We constructed a eukaryotic expression vector (pcDHOAT) which contains the SV40 promoter and human OAT cDNA. We used OAT(-) Chinese hamster ovary (CHO) cells, which have negligible OAT activity, and fibroblasts from a gyrate atrophy patient (GA35 cell), which have negligible OAT mRNA and enzyme. Incorporation of pcDHOAT and synthesis of human OAT mRNAs and active enzyme were demonstrated in both cell types. The level of expression of human OAT was low in the GA35 cells in comparison to the CHO cells. Despite the limited success, the ability to express active OAT in these OAT-deficient cells using an expression vector offers possibilities of replacement gene therapy for gyrate atrophy.

Original languageEnglish
Pages (from-to)28-32
Number of pages5
JournalJapanese Journal of Ophthalmology
Volume36
Issue number1
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Gyrate Atrophy
Ornithine-Oxo-Acid Transaminase
Cricetulus
Ovary
Fibroblasts
Enzymes
Messenger RNA
Genetic Therapy
Molecular Biology

Keywords

  • Expression
  • Gene therapy
  • Gene transfer
  • Gyrate atrophy
  • Ornithine aminotransferase

ASJC Scopus subject areas

  • Ophthalmology

Cite this

@article{e190fb16796741ce806f12d41253da27,
title = "Expression of human ornithine aminotransferase (OAT) in OAT-deficient Chinese hamster ovary celis and fibroblasts of gyrate atrophy patient",
abstract = "Gyrate atrophy is a hereditary chorioretinal degenerative disease caused by a deficiency of the mitochondrial enzyme, ornithine aminotransferase (OAT). Recent investigations have demonstrated the molecular genetic defects of OAT in gyrate atrophy patients. We constructed a eukaryotic expression vector (pcDHOAT) which contains the SV40 promoter and human OAT cDNA. We used OAT(-) Chinese hamster ovary (CHO) cells, which have negligible OAT activity, and fibroblasts from a gyrate atrophy patient (GA35 cell), which have negligible OAT mRNA and enzyme. Incorporation of pcDHOAT and synthesis of human OAT mRNAs and active enzyme were demonstrated in both cell types. The level of expression of human OAT was low in the GA35 cells in comparison to the CHO cells. Despite the limited success, the ability to express active OAT in these OAT-deficient cells using an expression vector offers possibilities of replacement gene therapy for gyrate atrophy.",
keywords = "Expression, Gene therapy, Gene transfer, Gyrate atrophy, Ornithine aminotransferase",
author = "Y. Hotta and George Inana",
year = "1992",
month = "1",
day = "1",
language = "English",
volume = "36",
pages = "28--32",
journal = "Japanese Journal of Ophthalmology",
issn = "0021-5155",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Expression of human ornithine aminotransferase (OAT) in OAT-deficient Chinese hamster ovary celis and fibroblasts of gyrate atrophy patient

AU - Hotta, Y.

AU - Inana, George

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Gyrate atrophy is a hereditary chorioretinal degenerative disease caused by a deficiency of the mitochondrial enzyme, ornithine aminotransferase (OAT). Recent investigations have demonstrated the molecular genetic defects of OAT in gyrate atrophy patients. We constructed a eukaryotic expression vector (pcDHOAT) which contains the SV40 promoter and human OAT cDNA. We used OAT(-) Chinese hamster ovary (CHO) cells, which have negligible OAT activity, and fibroblasts from a gyrate atrophy patient (GA35 cell), which have negligible OAT mRNA and enzyme. Incorporation of pcDHOAT and synthesis of human OAT mRNAs and active enzyme were demonstrated in both cell types. The level of expression of human OAT was low in the GA35 cells in comparison to the CHO cells. Despite the limited success, the ability to express active OAT in these OAT-deficient cells using an expression vector offers possibilities of replacement gene therapy for gyrate atrophy.

AB - Gyrate atrophy is a hereditary chorioretinal degenerative disease caused by a deficiency of the mitochondrial enzyme, ornithine aminotransferase (OAT). Recent investigations have demonstrated the molecular genetic defects of OAT in gyrate atrophy patients. We constructed a eukaryotic expression vector (pcDHOAT) which contains the SV40 promoter and human OAT cDNA. We used OAT(-) Chinese hamster ovary (CHO) cells, which have negligible OAT activity, and fibroblasts from a gyrate atrophy patient (GA35 cell), which have negligible OAT mRNA and enzyme. Incorporation of pcDHOAT and synthesis of human OAT mRNAs and active enzyme were demonstrated in both cell types. The level of expression of human OAT was low in the GA35 cells in comparison to the CHO cells. Despite the limited success, the ability to express active OAT in these OAT-deficient cells using an expression vector offers possibilities of replacement gene therapy for gyrate atrophy.

KW - Expression

KW - Gene therapy

KW - Gene transfer

KW - Gyrate atrophy

KW - Ornithine aminotransferase

UR - http://www.scopus.com/inward/record.url?scp=0026604093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026604093&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 28

EP - 32

JO - Japanese Journal of Ophthalmology

JF - Japanese Journal of Ophthalmology

SN - 0021-5155

IS - 1

ER -